About Enhancer

Enhancer ID: E_01_283
Enhancer symbol: DGKA Enhancer
Species: Human
Position : chr12:56330413-56330909
Biosample name: A9
Experiment class : Low+High throughput
Enhancer type: Enhancer
Disease: Fibrotic Disease
DO: --
Mesh: --
Distance from TSS: >2KB
Pubmed ID:  28916223
Enhancer experiment: ChIP-seq,PCR,ChIP
Enhancer experiment description: Analysis of publicly available data from the ENCODE project [18] (Fig. 1A), as well as our own ChIP experiments [8] revealed that the DGKA DMR carries H3K27ac. ChIP showed that JQ1 reduced the deposition of H3K27ac levels specifically at the DGKA enhancer site(DMR), but did not affect the upstream DGKA promoter sites 1 and 2 (Fig. 2C).

About Target gene

Target gene : DGKA(DAGK,DAGK1,DGK-alpha)
Strong evidence: --
Less strong evidence: ChIP,PCR
Target gene experiment description: From various NHDFs,we selected three fibroblast lines (data not shown) with significant differences in DGKA DNA methylation at the DGKA enhancer site(Fig. 1A) and inducible DGKA mRNA expression (Fig. 1B). Increased DNA methylation at the DGKA enhancer was associated with a lack of DGKA induction after exposure to bleomycin (Fig. 1B, Fibroblast3), confirming our previous findings in numerous patient-derived NHDF.EGR1 was significantly induced in two NHDF showing high DGKA induction (Fig. 1C).

About TF

TF name : EGR1(AT225,G0S30,KROX-24,NGFI-A,TIS8,ZIF-268,ZNF225)
TF experiment: qPCR
TF experiment description: Relative DGKA (B) and EGR1 (C) mRNA expression levels in three individual NHDF exposed to bleomycin (40 mM) or vehicle control (DMSO) for 48 h. *p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.0001, n.s. not significant.

About Function

Enhancer function : --
Enhancer function experiment: --
Enhancer function
experiment description:
--

About SNP

SNP ID: --
SNP position: --
SNP experiment: --

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs